SUMMARY The effects of DDD (fully automatic) and VVI (ventricular demand) pacing modes on exercise tolerance, symptom diary cards, and Holter monitoring were investigated in a randomised double blind crossover study of 16 patients who had had DDD pacemakers implanted because of frequent syncope. Eight patients presented with sick sinus syndrome and, with one exception, retrograde atrioventricular conduction and eight age and sex matched patients presented with 2:1 or complete atrioventricular block. Maximal symptom limited exercise in those with atrioventricular block was significantly higher after one month of DDD pacing than after VVI pacing. In those with sick sinus syndrome, however, maximal effort tolerance was not significantly different for the two pacing modes. In all but one patient with sick sinus syndrome sinus rhythm developed during exercise in VVI pacing. For both VVI and DDD modes maximal atrial rates were significantly lower in those with sick sinus syndrome. Palpitation and general wellbeing were significantly improved during DDD pacing in the eight patients with sick sinus syndrome. Shortness of breath was improved by DDD pacing in the eight patients with atrioventricular block but not in those with sick sinus syndrome. Holter monitoring showed that sick sinus syndrome patients remained in paced rhythm, either DDD or VVI, for most of the 24 hour period.
The availability of a reliable endocardial atrial lead'l ed to the development of "physiological" pacemakers that restore the normal activation sequence of atrial contraction followed by ventricular systole and that also permit a physiological increase in heart rate when the sinus rate increases.
Atrial demand pacemakers (AAI) were introduced as a physiological system for patients with sick sinus syndrome. They offered the same advantages as DDD (fully automatic) pacemakers but could not pace the ventricle if a fault developed in atrioventricular conduction. Subsequent development of atrioventricular block, carotid sinus hypersensitivity, and chronic atrial fibrillation made many of these patients unsuitable candidates for AAI pacRequests for reprints to Dr Richard Sutton, Westninster Hospital, Dean Ryle Street, London SW1P 2AP.
Accepted for publication 19 January 1988 ing45; however, not every study reported this problem.67 A recent review of the course of sick sinus syndrome suggests that those concerns are real.8
Atrial synchronous ventricular pacing (VAT, VDD) was unsuitable for patients with sick sinus syndrome because of the potential for persistent bradycardia which causes these units to pace in VVI mode at low rate. An atrioventricular sequential pacemaker (DVI) can be used for patients with sick sinus syndrome; however, Furman and Cooper9 reported a high incidence of atrial fibrillation with DVI pacing, possibly because of competition with atrial activity which is not sensed in this mode. Thus DDD appears to be an appropriate semi-physiological pacing mode for patients with sick sinus syndrome. This type of unit does not correct for the lack ofability ofthe sinus node to increase its rate normally on exercise. A future generation of DDD pacemakers will have an additional physiological sensor (other than the P wave) to offer this correction.
Benefits of dual chamber pacing in sick sinus syndrome Retrograde atrioventricular conduction is preserved in most patients with sick sinus syndrome who have intact atrioventricular conduction.' Pacemaker syndrome develops when atrioventricular synchrony is lost during VVI (ventricular demand) pacing with or without retrograde atrioventricular conduction.'2 13 Recent studies have emphasised the relation between preserved retrograde atrioventricular conduction and the development of pacemaker syndrome. ' Because of preservation of retrograde atrioventricular conduction, patients with sick sinus syndrome and without atrioventricular block potentially are at more Eight patients had sick sinus syndrome (group 1) and eight had atrioventricular block (group 2). The two groups were age and sex matched. All presented with frequent presyncope and syncope.
There was only one woman in group 1 (mean age 64-1 years (range 41-75)). All had symptomatic sick sinus syndrome, diagnosed electrocardiographically There were also seven men and one woman in group 2 (mean age 63-3 years (range 35-75)). All had symptomatic persistent 2:1 or complete atrioventricular block. No patients in group 2 had retrograde atrioventricular conduction, but four had ischaemic heart disease (two with previous myocardial infarction and two with angina of effort).
Patients had had their pacemaker implanted in DDD mode for a mean of 23 months (group 1, 20 months; group 2, 27 months) before entry into the trial to ensure that they were haemodynamically stable at entry.
TRIAL PROTOCOL
The trial was designed as a within patient double blind prospective study of symptoms and exercise tolerance between the two pacing modes with sufficient time in each mode to permit adaptation. Patients were investigated as outpatients. All patients were programmed in DDD mode before the trial began. We asked patients to keep diary cards of their symptoms for two consecutive months, and a Holter 24 hour period was recorded (sick sinus syndrome patients only) and a maximal stress test was performed at the end of each study period. During the first Mitsuoka, Kenny, Yeung, Chan, Perrins, Sutton month the pacemaker mode was randomly programmed to either the WI or DDD mode. For the second month the alternative mode was programmed. Table  2 shows the sequence of modes for each patient.
At the end ofeach study month patients performed a symptom limited maximum exercise stress test on an electrically braked bicycle ergometer (Siemens Elema). Before entry to the trial patients also had two exercise stress tests to familiarise themselves with the bicycle ergometer and to eliminate a training effect. Exercise was started for a minimum of three minutes at 35 W and continued to maximum capacity with 35 W increases in workload every three minutes. We recorded the total workload achieved (in Watts). Blood pressure was recorded by conventional mercury sphyginomanometer and heart rate was recorded on a three lead electrocardiograph. Blood pressure and heart rate were recorded on the bicycle before exercise, at the end of every three minute stage, and every two minutes for 10 minutes after exercise.
Patients with sick sinus syndrome (group 1) also had 24 hour Holter monitoring by Oxford Medilog (Oxford Medical Instruments) at the end of each month. Bipolar electrocardiographic chest leads were fixed to the chest at the VI and V6 positions. All electrograms were recorded for 24 hours while patients were ambulant at home and at work. Patients kept a diary card throughout the recording period. The electrocardiographic tape recordings were printed by fibreoptic printer (Oxford Medical Instruments) at a paper speed 25 mm/s. The electrocardiographic pattern was sampled over every first and thirty first minute each hour to measure the mean heart rate, diurnal variation of heart rate, and use of the pacemaker. If atrial arrhythmia was present during the observation minute, the rate was not included in the analysis.
Mean heart rate was defined as the average heart rate during Holter recording. Diurnal variation of heart rate was assessed by comparing the average heart rate at night (from 1 to 4 am) with the average heart rate by day (from 1 to 4 pm). We defined pacemaker use as the percentage of beats recorded while the atrial, atrioventricular sequential, or ventricular modes were operating. Atrial synchronous pacing (VDD mode of operation) was considered as sinus-like activity. We defined maximum heart rate as the fastest sinus rate. If the sinus rate did not exceed the pacemaker back up rate, the back up rate was taken as the maximum heart rate.
We also analysed the incidence and frequency of cardiac arrhythmias. We measured the duration of paroxysmal atrial fibrillation (fibrillation of more than 5 consecutive beats) and we used the following identification criteria to measure extrasystoles (a)
Benefits of dual chamber pacing in sick sinus syndrome configuration differing from the regular QRS or pacemaker induced complexes; (b) wide complexes (> 0.12 s); (c) no preceding P wave; (d) prematurity. Frequency was calculated as the number of extrasystoles per 1000 complexes.
We also assessed pacemaker mediated tachycardia. Pacemaker mediated tachycardia was defined as a tachycardia associated with dual chamber sensing pacemakers, which detect a retrograde P wave and conduct anterogradely through the pacing system to trigger another ventricular stimulus and thus perpetuate the tachycardia.
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DIARY CARDS
The subjective "feeling of general wellbeing" was significantly better in the DDD mode for both groups (p < 0.05) (table 3 and fig 3) .
The subjective assessment of "shortness of breath" was also better for DDD pacing in atrioventricular block (3. 3 and fig 4) . In sick sinus syndrome, 50O of patients were more breathless in the VVI mode. monitored the electrocardiogram but took no part in the subsequent data analysis.
This prospective controlled study showed that DDD pacing is better than VVI in patients with sick sinus syndrome, although there was no difference in effort tolerance between the modes and sinus rhythm developed on each occasion. The beneficial effects of the DDD mode in sick sinus syndrome were evident from the analysis of diary cards. Subjective symptoms of palpitation were significantly (p < 0 05) less during DDD pacing; also the patient's overall feeling of wellbeing was significantly (p <005) improved. Shortness of breath, however, may be regarded as an exercise related symptom and DDD pacing was not better than VVI pacing in counteracting this symptom in the patients with sick sinus syndrome. In contrast, in patients with atrioventricular block DDD pacing had beneficial effects on both exercise tolerance and shortness ofbreath. Two patients were unable to tolerate VVI mode and required reprogramming to DDD before completion of the study period. One patient had sick sinus syndrome and the other had atrioventricular block. Both complained of palpitation, shortness of breath, and chest pain (non-anginal) which lasted for seconds to over an hour. These two patients had pacemaker syndrome in VVI.
This study design differed from that of Perrins et all' in that there was no randomised run-in period of one month before the trial itselfbegan. All patients in both groups were in DDD before the trial. So after the first month the effects ofthe DDD mode could be compared with the DDD mode that was previously programmed in nine patients (four in group 1, and five in group 2). As expected, seven reported no change in shortness of breath but two reported an 345 improvement. Both these patients also reported adverse effects when they changed to the VVI mode. Seven patients reported no change in wellbeing after the first month of study and two reported an improvement. Again both of them reported adverse effects in the second month when the VVI mode was operating. Only group 1 had a statistically significant difference between the modes for palpitation. None of the patients with no mode change in the first month reported a change but two ofthem reported an adverse effect when they changed to VVI in the second month of the trial. For shortness of breath in group 1 DDD was better than VVI in four, with no change in four; and for group 2 DDD was better in seven, with no change in one. For general wellbeing in group 1 DDD was better than VVI in four patients, with no change in four, and in group 2 DDD was preferred by eight with no change in one and VVI was favoured by one who had angina in the DDD mode. For palpitation five group 1 patients preferred DDD and three reported no difference. So only the patient who had angina in DDD preferred the VVI mode. These results indicate that the omission of the one month run-in period did not affect the comparison of the two pacemaker modes.
Pacemaker syndrome normally presents with symptoms of dizziness, syncope, chest pain, and shortness of breath. Several mechanisms have been proposed to explain this syndrome. '3 7 In the presence of retrograde atrioventricular conduction, left atrial pressure rises and cardiac output falls. This results in hypotension, which may be compounded by an inappropriate response in total peripheral resistance.'7" When retrograde atrioventricular conduction is not present, competition between sinus rhythm and ventricular pacing may induce hypotension by causing an acute and transient loss of atrioventricular sychrony.? In this study, most ofthe patients with sick sinus syndrome who completed the one month study period in VVI mode had symptoms and could be regarded as having a form of pacemaker syndrome (figs 3-5 and tables 3 and 4).
EXERCISE TESTING
Perrins et al" found that exercise tolerance and symptoms were better in patients with atrioventricular block in VDD (atrial triggered pacing) than in VVI pacing. In the VDD mode, if the atrial rate falls below the programmed low rate, the pacemaker functions as a VVI unit and this makes it unsuitable for pacing patients with sick sinus syndrome. In contrast, as the spontaneous rate decreases in DDD, the pacemaker paces sequentially in the atria and ventricles. In the present study symptomatic assessment of shortness of breath and general wellbeing in patients with atrioventricular block showed similar 346 results to the study of Perrins et al."6 But they found no difference in the frequency of chest pain between the VDD and VVI modes whereas two ofour patients with atrioventricular block had frequent episodes of angina in the DDD mode. In VVI one patient had no angina and the other had an appreciable reduction in anginal episodes. These differences probably reflect differences in patient selection for these two small samples. Kristensson et al reported that a reduction in the upper rate in DDD improves the control of angina in patients with ischaemic heart disease.2" Kenny et al confirmed this finding using a double blind technique.'
We compared the effect of the DDD mode in sex and age matched subjects with sick sinus syndrome and atrioventricular block. Effort tolerance was better in those with sick sinus syndrome than in those with atrioventricular block, but this difference was not statistically significant. It is possible that four of eight patients with atrioventricular block had ischaemic heart disease which may have limited their exercise tolerance without producing angina. Atrial rates at rest and at peak exercise were significantly lower in patients with sick sinus syndrome for both pacemaker modes. Holden et al also showed that there was no difference in effort tolerance in patients with sick sinus syndrome and normal age matched controls but atrial rates at peak exercise were lower in patients with sick sinus syndrome.2" The maintenance of effort tolerance may be the result of haemodynamic adaptation to the relative sinus bradycardia in patients with sick sinus syndrome by augmentation of stroke volumes' which suggests that in these patients maintenance of atrioventricular synchrony is more valuable haemodynamically than rate responsiveness on exercise.
It can be difficult to diagnose sick sinus syndrome in the presence of atrioventricular block. In the present study we assessed sinus node dysfunction in patients with atrioventricular block by routine electrocardiography, sinus node recovery times, and by Holter recordings. We found no abnormalities.
HOLTER MONITORING
Holter monitoring showed that the maximal sinus rates achieved on exercise testing are not seen in daily life and that patients spend much of their day with their hearts driven by their pacemakers. This accounts for the better symptomatic benefit shown by the diary cards for dual chamber pacing in terms of general wellbeing, dizziness, and palpitation.
In VVI mode, with a back up rate of 70 beats/min, patients used their pacemakers 77% of the time.
Adverse symptoms in VVI mode are associated with retrograde atrioventricular conduction. It is of interest to note the degree of pacemaker use within a Mitsuoka, Kenny, Yeung, Chan, Perrins, Sutton 24 hour period. Previous work showed that VVI pacing at 50 beats/min produces fewer adverse symptoms than rates of 70 beats/min.24 This is directly related to the proportion of time that the heart is driven by the pacemaker. The DDD mode may have been better than the VVI mode in the present series because of the lower back up rate for DDD (60 v 70 beats/min). None the less, if retrograde atrioventricular conduction is present, VVI pacing will cause symptoms, whatever the pacing rate. In addition, if the back up rate is low, bradycardia may itself cause symptoms. The short runs of pacemaker mediated tachycardia in two patients were asymptomatic and such events can often be prevented by appropriate programming of the DDD mode.
This study shows that dual chamber pacing may be better than VVI in the prevention of paroxysmal atrial fibrillation ( fig 6, table 5 ). Sick sinus syndrome is associated with a high incidence of both atrial fibrillation and systemic embolism,2" which are likely to be related features. 26 The aim of atrial stimulation is to prevent bradycardia dependent atrial tachycardias and, by implication, systemic embolism. So far there is no convincing data to suggest that this has been achieved. Some workers, however, have shown a lower incidence of stroke, heart failure, and chronic atrial fibrillation when AAI pacing rather than VVI pacing is used27 &" but no controlled studies have yet been reported.
Ours was a small short term study and other larger studies have been short term too, so we cannot be certain that suppression of atrial arrhythmias in sick sinus syndrome will persist. Atrial stimulation alone is unlikely to control all atrial arrhythmias, and some patients may also need antiarrhythmic drugs and even anticoagulants. DVI pacing improved symptoms in sick sinus syndrome more than VVI,' but Furman and Cooper suggest that the increased incidence of atrial arrhythmias in this dual chamber mode is presumably caused by its lack of an atrial demand feature. 9 We found that DDD pacing was better than VVI pacing in patients with sick sinus syndrome, particularly those with retrograde atrioventricular conduction. Every sick sinus syndrome patient requiring cardiac stimulation should be considered as a candidate for dual chamber pacing. In this study we did not compare DDD with atrial demand pacing (AAI).
However, a difference between AAI and DDD is unlikely in these patients who showed no evidence of atrioventricular block at pacemaker implantation. If DDD pacing is better than AAI we expect that it would appear by protecting against the development of atrioventricular block during the lifetime of the pacemaker which, with presently available dual chamber units, may be six years or more. There was progession to atrioventricular block causing clinical concern in 8 4% of patients with no initial atrioventricular conduction defect in a period of 34-2 months in a review of 1395 published cases. 8 In the future it may prove valuable to use the DDI mode of pacing rather than DDD. In DDI both sets of chambers are paced on demand but atrial triggering of ventricular stimulation does not occur, which prevents the possibility ofdevelopment ofpacemaker mediated tachycardia and this avoids atrial tachycardias triggering a rapid ventricular rate, while DDI still provides all the other attributes of a DDD pacemaker. DDDR pacemakers are becoming available being equipped with an additional sensor to permit dual chamber rate responsive pacing (R) in the event ofa lack of response to exercise by the atria. These pacemakers need careful evaluation both in terms of control of symptoms and of atrial arrhythmias and their suppression.
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